| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | CN100412075C Process for preparing L-ofloxacin and ofloxacin |
| 08/20/2008 | CN100412064C Malononitrile compounds and its use |
| 08/20/2008 | CN100412062C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/19/2008 | US7414157 Hydroxylation of β-dicarbonyls with zirconium catalysts |
| 08/19/2008 | US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 08/19/2008 | US7414052 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/14/2008 | WO2008098103A1 Method for preparing halogenated amines |
| 08/14/2008 | WO2008019292A3 Compositions and methods for potentiating antibiotic activity |
| 08/14/2008 | US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound |
| 08/14/2008 | US20080194585 Fungicidal Pyrazine Derivatives |
| 08/14/2008 | US20080194583 Tubulin Inhibitors |
| 08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| 08/14/2008 | US20080194520 Sulfonyl Amino Cyclic Derivatives and Use Thereof |
| 08/14/2008 | US20080193794 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance |
| 08/14/2008 | US20080193423 Small organic molecule regulators of cell proliferation |
| 08/14/2008 | CA2677656A1 Method for preparing halogenated amines |
| 08/13/2008 | EP1956011A1 Amine compound and organic electroluminescent element employing the same |
| 08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101243067A Novel anthranilamides for controlling invertebrate pests |
| 08/13/2008 | CN101239952A Technique for synthesizing levodropropizine |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410968 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 08/07/2008 | US20080188659 Method for Preparing Halogenated Amines |
| 08/07/2008 | US20080188654 Compounds for treatment of inflammation, diabetes and related disorders |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist; |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188488 Heterocyclic Derivatives and Their Use as Stearoyl-Coa Desaturase Inhibitors |
| 08/07/2008 | US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 08/07/2008 | US20080185555 Such as 2,3:6,7-anthracenedicarboximide derivatives; air stability, solution processability; n type; organic thin film transistors, light emitting diodes and photovoltaic devices; long lasting |
| 08/06/2008 | EP1951688A1 A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
| 08/06/2008 | EP1951687A1 N-hydroxyamide derivatives and use thereof |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | EP1267819B1 Quinoxaline derivatives, compositions containing them und use as UV-filter |
| 08/05/2008 | US7407959 N1-(1-cyanocyclopropyl)-N2-(1-{4'-[2,2-difluoro-1-hydroxyethyl]biphenyl-4-yl}-2,2,2-trifluorethyl)-4-fluoro-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/05/2008 | US7407958 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 08/05/2008 | CA2286796C Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 08/05/2008 | CA2208573C Process for preparing 1,4,5,6-tetrahydropyrazine-2-carboxamides |
| 07/31/2008 | WO2008092049A1 Anthranilamide inhibitors of aurora kinase |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 07/31/2008 | WO2008042896A3 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 07/31/2008 | WO2007077201A9 Piperazine compounds with a herbicidal action |
| 07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
| 07/31/2008 | US20080182852 Anthranilamide inhibitors of aurora kinase |
| 07/31/2008 | US20080182846 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 07/31/2008 | US20080182838 (5-{5-[4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl]pyrazin-2-yl}-2H-tetrazol-2-yl)acetic acid; metabolic disorders,antidiabetic, hypoglycemic agent; obesity, insulin resistance, liver steatosis, atherosclerosis, neurological disease, dyslipidemia, hyperlipidemia, low HDL, and high LDL |
| 07/31/2008 | CA2676257A1 Anthranilamide inhibitors of aurora kinase |
| 07/30/2008 | EP1950212A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/30/2008 | EP1948622A1 Tricyclo substituted amides as glucokinase modulators |
| 07/30/2008 | EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 07/30/2008 | EP1606267B1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 07/30/2008 | CN101230043A 3-oxide-2-methylamide derivatives as well as preparation method and use thereof |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406458C Novel heterocycle naphthoylimine and double-chain compound and its uses in tumour cell |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405299 Compounds as pharmaceutical agents |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/25/2008 | CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/24/2008 | WO2008089283A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
| 07/24/2008 | WO2008087514A2 Hdac inhibitors |
| 07/24/2008 | US20080177072 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma |
| 07/24/2008 | US20080177066 reacting 2-chloro-sustituted pteridinones with para-aminobenzamides in the presence of acid catalysts, to form pteridinone derivatives having antiproliferative activity |
| 07/24/2008 | US20080176863 Capped pyrazinoylguanidine sodium channel blockers |
| 07/24/2008 | US20080176838 e.g. [3-[(Cyclopropanecarbonyl-amino)-methyl]-pyrrolidin-1-yl}-(2-fluoro-benzyl)-propyl]-carbamic acid tert-butyl ester; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes; |
| 07/24/2008 | US20080176763 Collection of Traceable Compounds and Uses Thereof |
| 07/24/2008 | CA2675743A1 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | CN101228129A Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 07/23/2008 | CN100404537C Quinazolin allkaloids compound, preparation method and use thereof |
| 07/23/2008 | CN100404535C Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 07/22/2008 | US7402675 Process for the synthesis of amine ethers from secondary amino oxides |
| 07/22/2008 | CA2268411C Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | US20080171880 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; absorbed less rapidly from mucosal surfaces, less reversible |
| 07/17/2008 | US20080171879 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 07/17/2008 | US20080171754 Certain pyrazoline derivatives with kinase inhibitory activity |
| 07/16/2008 | EP1943238A1 Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70 |
| 07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | CN101223141A Certain substituted amides, method of making, and method of use thereof |
| 07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 07/15/2008 | US7399884 Substituted benzamides; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations |
| 07/15/2008 | US7399766 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 07/15/2008 | US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |